Table 3. Follow-up of pregnant women with IBD treated by modality incorporating PBD and follow-up of their PBDS.
| Follow-up & PBDS | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Mean [SD] | Median [IQR] |
|---|---|---|---|---|---|---|---|---|---|---|
| Final follow-up | ||||||||||
| Period after 1st hospitalization (months) | 12 | 65 | 51 | 87 | 47 | 223 | 76 | 161 | 90 [69] | 71 [48–143] |
| Stage (severity) | S0 | S0 | S0 | Remission | S0 | S0 | S0 | S0 | – | – |
| Medication | None | None | None | Scheduled IFX maintenance | None | Mesalamine | Betamethasone supp as needed | None | – | – |
| PBDS | ||||||||||
| Base | 8 | 11→2† | 11 | 5 | 25→9† | 27 | 22 | 4 | 14.1 [9.2] | 11.0 [5.8–24.3] |
| Short term | ||||||||||
| PBDS | 19 | 36 | 20 | 27 | 40 | Not available | Not available | Not available | 28.4 [9.4] | 27.0 [19.5–38.0] |
| Follow-up period (months) | 12 | 3 | 6 | 6 | 1 | Not available | Not available | Not available | 5.6 [4.2] | 6 [2–9] |
| Long term | ||||||||||
| PBDS | Not applicable | 12 | Not applicable | 20 | 27 | 29 | Not applicable | 19 | 21.4 [6.8] | 20.0 [15.5–28.0] |
| Follow-up period (months) | Not applicable | 47 | Not applicable | 40 | 29 | 120 | Not applicable | 85 | 64 [38] | 47 [35–103] |
†, changed diet prior to onset of ulcerative colitis. Not available: not available was due to the author’s failure to obtain a food-frequency questionnaire during follow-up. IBD, inflammatory bowel disease; PBD, plant-based diet; PBDS, plant-based diet score; SD, standard deviation; IQR, interquartile range; S0, remission in severity of ulcerative colitis (18); IFX, infliximab; supp, suppository.